Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report

We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side...

Full description

Bibliographic Details
Main Authors: Holger Michel, Frank Heißenhuber, Sven Wellmann, Michael Melter, Stephan Gerling
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00313/full
id doaj-6ab15c9a69504c7ab3b269f603edff5c
record_format Article
spelling doaj-6ab15c9a69504c7ab3b269f603edff5c2020-11-25T02:27:26ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-06-01810.3389/fped.2020.00313503086Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case ReportHolger Michel0Frank Heißenhuber1Sven Wellmann2Michael Melter3Stephan Gerling4University Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyClinic for Cardiology-Electrophysiology, Hospital Barmherzige Brüder, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyWe report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the literature.https://www.frontiersin.org/article/10.3389/fped.2020.00313/fulltachycardiaatrialIvabradinebeta-blockerchildrencase report
collection DOAJ
language English
format Article
sources DOAJ
author Holger Michel
Frank Heißenhuber
Sven Wellmann
Michael Melter
Stephan Gerling
spellingShingle Holger Michel
Frank Heißenhuber
Sven Wellmann
Michael Melter
Stephan Gerling
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
Frontiers in Pediatrics
tachycardia
atrial
Ivabradine
beta-blocker
children
case report
author_facet Holger Michel
Frank Heißenhuber
Sven Wellmann
Michael Melter
Stephan Gerling
author_sort Holger Michel
title Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
title_short Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
title_full Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
title_fullStr Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
title_full_unstemmed Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
title_sort ectopic atrial tachycardia in a 12-month-old girl treated with ivabradine and beta-blocker, a case report
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2020-06-01
description We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the literature.
topic tachycardia
atrial
Ivabradine
beta-blocker
children
case report
url https://www.frontiersin.org/article/10.3389/fped.2020.00313/full
work_keys_str_mv AT holgermichel ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport
AT frankheißenhuber ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport
AT svenwellmann ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport
AT michaelmelter ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport
AT stephangerling ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport
_version_ 1724843181138247680